SCHEMBL16201776

SCHEMBL16201776

C=CC[C@@H](C(N)=O)[C@H](O)CCc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.41
ERAP1 Q9NZ08 4/20 0.40
ERAP2 Q6P179 3/20 0.40
ANPEP P15144 2/20 0.40
METAP2 P50579 1/20 0.39
METAP1 P53582 1/20 0.39
MAPT P10636 1/20 0.39
MMP2 P08253 2/20 0.38
MMP3 P08254 1/20 0.38
MMP7 P09237 1/20 0.38
CNR2 P34972 1/20 0.38
TRPA1 O75762 1/20 0.38
TSHR P16473 1/20 0.38
ADA P00813 2/20 0.38
DPP4 P27487 1/20 0.38
KMT2A Q03164 1/20 0.37
EPHX1 P07099 1/20 0.37
IL1RN P18510 2/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16201773 1.00 CYP2C19 (0.41) CYP2C19ERAP1ERAP2ANPEPMETAP2
SCHEMBL16201821 0.92 GRIK1 (0.43) CYP2C19MAPTMMP2MMP3MMP7
SCHEMBL16201801 0.92 GRIK1 (0.43) CYP2C19MAPTMMP2MMP3MMP7
SCHEMBL16201788 0.88 CYP2C19 (0.46) CYP2C19ERAP1ERAP2ANPEPMAPT
SCHEMBL16201771 0.88 CYP2C19 (0.46) CYP2C19ERAP1ERAP2ANPEPMAPT
SCHEMBL16201782 0.85 EPHX1 (0.46) CYP2C19MMP2MMP3MMP7TRPA1
SCHEMBL16201819 0.85 EPHX1 (0.46) CYP2C19MMP2MMP3MMP7TRPA1
SCHEMBL16194341 0.84 ERAP1 (0.46) ERAP1ERAP2ANPEPMETAP2METAP1
SCHEMBL16201815 0.84 ERAP1 (0.46) ERAP1ERAP2ANPEPMETAP2METAP1
SCHEMBL16194340 0.84 ERAP1 (0.46) ERAP1ERAP2ANPEPMETAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323457-A1 BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS Technische Universität München (DE) 2014-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323457-A1 BETA-O/S/N FATTY ACID BASED COMPOUNDS AS ANTIBACTERIAL AND ANTIPROTOZOAL AGENTS FASN, DEGS1, EBP CYP2C19 2114/4885ERAP1 2859/4885ERAP2 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.